References
- StewartBWPaul KleihuesPWorld Cancer ReportLyon, FranceInternational Agency Research on Cancer2003
- ParkinDMSitasFChirenjeMSteinLAbrattRWabingaHPart I: Cancer in indigenous Africans – burden, distribution, and trendsLancet Oncol20089768369218598933
- AlisonMalcolm RCancerLondon, UKImperial College, School of Medicine, encyclopedia of life science20012743
- JavedSAliMSadiaSAslamMAMasoodAIShaikhRSSayyedAHCombined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani populationMaturitas201169437738221684697
- WarrDGChemotherapy- and cancer-related nausea and vomitingCurr Oncol200815Suppl 1S4S918231647
- ChabnerBAGeneral principles of cancer chemotherapyBruntonLChabnerBKnollmanBGoodman and Gilman’s The Pharmacological Basis of Therapeutics12th edNew York, NYMcGraw Hill Inc201116671675
- World Health OrganizationInternational Drug Monitoring: The Role of the HospitalGenevaWorld Health Organization1996Technical Report Series, No. 425
- ParthasarathiGOlssonSAdverse drug reactionsParthasarathiGKarinNyfort-HansenNahataMCA Textbook of Clinical Pharmacy Practice1st edChennai, IndiaOrient Longman200488486
- GandhiTKBartelSBShulmanLNMedication safety in ambulatory chemotherapy settingCancer2005104112477248316245353
- RabburRSEmmertonLAn introduction to adverse drug reaction reporting system in different countriesInt J Pharm Prac200513191100
- LauPMStewartTKDooleyMThe ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?Support Care Cancer200412962663315064936
- AlbiniADonatelliFNoonanDD’eliosMMPriscoDBringing new players into the field: onco-pharmacovigilance in the era of cardio-oncologyIntern Emerg Med2012729910122271393
- MekuriaABErkuDABelachewSAPreferred information sources and needs of cancer patients on disease symptoms and management: a cross-sectional studyPatient Prefer Adherence2016101991199727729777
- ArandaSJeffordMYatesPImpact of a novel nurse-led pre chemotherapy education intervention on patient distress, symptom burden, and treatment-related information and support needs: results from a randomized, controlled trialAnn Oncol201223122223121471562
- World Health OrganizationUppsala Monitoring CenterCausality assessment of suspected adverse reactions 2014 Available from: http://who.umc.org/graphics/24734.pdfAccessed June 26, 2016
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508
- National Cancer InstituteCommon Terminology Criteria for Adverse Events (CTCAE), Version 4.0 Available from: http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdfAccessed June 1, 2016
- BalmerCMValleyAWIannucciACancer treatment and chemotherapyPharmacotherapy: A Pathophysiologic Approach6th edUSAMcGraw-Hill Companies20052279
- PrasadADattaPPBhattacharyaJPattanayakCChauhanASPandaPPattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Eastern IndiaJ Pharmacovigilance20131107
- BlackerKSternRWeintraubBUCutaneous reactions to drugsDermatology in General MedicineNew York, NYMcGraw-Hill200317831794
- JoseJRaoPGPattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospitalPharmacol Res200654322623316781163
- HickokJTRoscoeJAMorrowGR5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomized controlled trialLancet Oncol200561076577216198982
- GrunbergSMAntiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysisAnn Oncol200718223324017108149
- HanlonJTRubyCMArtzMGeriatricsDiPiroJTTalbertRLYeeGCMatzkeGRWellsBGPoseyLMPharmacotherapy A Pathophysiologic Approach5th edNew York, NYMcGraw Hill Inc20027989
- BatesDWLeapeLAdverse Drug Reaction, Morreli’s Clinical Pharmacology4th edBoston, USAMcGraw-Hill2000
- PoddarSSultanaRSultanaRAkborMMAzadMAHasnatAPattern of adverse drug reactions due to cancer chemotherapy in tertiary care teaching hospital in BangladeshDhaka Univ J Pharm Sci200981116
- ChanHKIsmailSSide effects of chemotherapy among cancer patients in a Malaysian general hospital: experiences, perceptions and informational needs from clinical pharmacistsAsian Pac J Cancer Prev201415135305530925040993
- NavariRMManagement of chemotherapy-induced nausea and vomitingDrugs201373324926223404093
- RojasCSlusherBSPharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomitingEur J Pharmacol20126841–31722425650
- SangerGJAndrewsPLTreatment of nausea and vomiting: gaps in our knowledgeAuton Neurosci20061291–231616934536
- LazarouJPomeranzBHCoreyPNIncidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJ Am Med Assoc19982791512001205
- DonowitzGRMakiDGCrinhCJPappasPGRolostonKVInfections in the neutropenic patients’ new views of an old problemHematology Am Soc Hematol Educ Program200111314811722981
- BodeyGPBuckleyMSatheYSFreireichEJQuantitative relationships between circulating leukocytes and infection in patients with acute leukemiaAnn Intern Med19666423283405216294
- LudwigHFritzEAnemia in cancer patientsSemin Oncol199825726
- O’BrienCNausea and vomitingCan Fam Physician200854686186318556493
- CaggianoVStolshekBSDelgadoDJCarterWBFirst and all cycle febrile neutropenia hospitalizations (FNH) and costs in intermediate grade non-Hodgkin’s lymphoma (IGL) patients on standard-dose CHOP therapyBlood20019811431